Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Papers: 21 Aug 2015 - 28 Aug 2015
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
MS Research Roundup: May 27, 2014
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Icariin exerts estrogen-like activity in ameliorating EAE via mediating estrogen receptor β, modulating HPA function and glucocorticoid receptor expression.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Co-occurrence of multiple sclerosis and Parkinson disease.
[The biological role of sulfatides].

Pages